Testicular cancer is a rare condition, accounting for approximately 1-1.5% of all cancers in men. It is the most common cancer affecting men in their 20s and 30s. Little is known about the exact cause of this disease, although numerous risk factors have been recognised.
Treatment of testicular cancer has been extremely successful, with impressive cure rates reported. This is due to the excellent tumour response to chemotherapy and radiotherapy, and also to the diagnosis and follow-up regimes.
Bosel GJ , Motzel RJ.Testicular germ-cell cancer . N Engl J Med1997;337; 242-253
2.
Bukowski RM.Management of advanced and extragonadal germ-cell tumours . Urol Clin North Am1993;20(1); 153-160
3.
Fair W , Dalbagni G , Machele Donat S , Theodorescu D.Evaluation and follow-up of patients with urologic cancer. Linthicum, MD: AUA Office of Education Publications , 1999
4.
Huyghe E , Matsuda T , Thonneau P.Increasing incidence of testicular cancer worldwide: a review . J Urol2003;170(1): 5-11
5.
Laguna MP , Pizzocaro G , Klepp O , Algaba F , Kisbenedek L , Leiva O , et al.EAU guidelines on testicular cancer . Eur Urol2001;40(2); 102-110
6.
Oliver RT.Factors contributing to delay in diagnosis of testicular tumours . BMJ (Clin Res Ed)1985;290(6465); 356
7.
Shelley MD , Burgon K , Mason MD.Treatment of testicular germ-cell cancer: a Cochrane evidence-based systematic review . Cancer Treat Rev2002;28(5): 237-253
8.
Spermon JR , Kiemeney LA , Meuleman EJ , Ramos L , Wetzels AM , Witjes JA.Fertility in men with testicular germ cell tumors . Fertil Steril2003;79(Suppl 3): 1543-1549
